Unveiling Post-COVID-19 Syndrome: Incidence, Biomarkers, and Clinical Phenotypes in a Thai Population

    October 2024 in “ BMC Infectious Diseases ”
    Sorawat Sangkaew, Hathaitip Tumviriyakul, Chutima Cheranakhorn, Nopporn Songumpai, Nawamin Pinpathomrat, Bunya Seeyankem, Kameelah Yasharad, Palanthorn Loomcharoen, Wisitsak Pakdee, Chanunya Changawej, Dararat Dumrongkullachart, Amornrat Limheng, Ilaria Dorigatti
    Studysummary This study found that post-COVID-19 syndrome incidence varied significantly by gender and identified ALP levels as a potential biomarker for its detection, challenging current diagnostic criteria.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study on Post-COVID-19 syndrome (PCS) in a Thai population involved 300 COVID-19 survivors, revealing that 47% developed PCS, with a higher incidence in females (79.4%) compared to males (54.7%). Common symptoms included hair loss (22%) and fatigue (21%). Alkaline phosphatase (ALP) was identified as a significant biomarker for PCS, suggesting its potential for early detection. The study identified four distinct clinical phenotypes, emphasizing the need for a holistic approach to PCS diagnosis that includes quality of life considerations. This approach could lead to personalized interventions, improving patient outcomes and resource allocation.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results